How can I determine if a patient has hepatitis?

Diagnosing Hepatitis: A Structured Testing Approach

Begin with serological testing for hepatitis antibodies (HCV antibody, HBsAg for hepatitis B), followed immediately by nucleic acid testing (NAT) for viral RNA/DNA if antibodies are positive, to distinguish current infection from past resolved infection. 1

Initial Testing Strategy

For Hepatitis C Detection

• Start with HCV antibody testing using either a rapid test or laboratory-based assay 1
• A reactive (positive) HCV antibody result requires immediate follow-up with HCV RNA testing to determine if infection is current 1
• If HCV RNA is detected, this confirms current HCV infection 1
• If HCV RNA is not detected, this indicates either past resolved infection or false antibody positivity 1

Critical timing consideration: HCV antibody may be negative during the first 6 weeks after exposure, and seroconversion may be delayed in immunosuppressed patients 1

For Hepatitis B Detection

• Test for hepatitis B surface antigen (HBsAg) as the primary marker 2
• Serological testing should include HBsAg, anti-HBs (surface antibody), and anti-HBc (core antibody) to establish infection status and immunity 3
• HBV DNA testing confirms active viral replication and degree of infectivity 2

Clinical Indicators That Should Trigger Testing

High-Risk Populations Requiring Testing

• Patients born in countries where viral hepatitis is prevalent - this strategy provides high efficiency with minimal loss of sensitivity 4
• Evidence of intravenous drug use 4
• Patients with ALT levels more than twice the upper limit of normal - this has high predictive value for viral hepatitis 4
• Patients with abnormal liver function tests (LFTs) 4

Acute Hepatitis C Specific Indicators

• Fluctuating ALT peaks suggest acute infection, though ALT may be normal during acute HCV infection 1
• Viral fluctuations >1 log10 IU/mL may indicate acute HCV infection 1
• Note that HCV RNA may be transiently negative during acute infection 1

Practical Testing Algorithm

For patients with abnormal LFTs: Testing all patients for viral hepatitis without repeating LFTs is more cost-efficient than the traditional approach of repeating LFTs first 4

Efficient "Fast and Frugal" Heuristic

1. First tier: Test all patients with clear clinical indication of infection (e.g., IV drug use) 4
2. Second tier: Test all patients who originated from countries where viral hepatitis is prevalent 4
3. Third tier: Test those with ALT more than twice the upper limit of normal 4

Confirmatory and Supplemental Testing

For Hepatitis C

• Use the same blood sample for reflex HCV RNA testing if the initial HCV antibody is reactive - this avoids additional blood draws 1
• For patients tested with rapid fingerstick tests (OraQuick), a separate venipuncture sample is needed for RNA testing 1
• If distinguishing true positivity from false positivity is needed, use a second FDA-approved HCV antibody assay different from the initial test 1

For Recent Exposures

• For patients potentially exposed within the past 6 months, test for HCV RNA directly or plan follow-up antibody testing, as antibodies may not yet be detectable 1
• For immunocompromised patients, HCV RNA testing should be considered even with negative antibodies 1

Additional Baseline Assessment

Once infection is confirmed, assess disease severity using:

• Routine blood tests: ALT, AST, albumin, bilirubin, INR, CBC with platelet count 1
• Serum fibrosis marker panels (APRI, FIB-4 score) 1
• Transient elastography for non-invasive fibrosis assessment 1
• Liver imaging (ultrasound or CT scan) 1

Common Pitfalls to Avoid

• Do not rely on antibody testing alone - it cannot distinguish between current and past infection 1
• Do not assume normal ALT excludes hepatitis - ALT may be normal during both acute and chronic infection 1
• Do not delay RNA/DNA testing - waiting for repeat LFTs is less efficient than immediate viral testing 4
• Do not miss the window period - antibodies may not appear for 6 weeks after HCV exposure 1
• Remember that clinical presentation alone cannot distinguish between hepatitis A, B, C, D, or E - serological testing is essential for precise diagnosis 5